Riitta Lassila
Papers
1
Total Citations
15
H-Index
1
About
Riitta Lassila is a leading haematologist and researcher whose work focuses on thrombosis, haemostasis, and surgical coagulation management. Her key contributions lie in understanding how major surgical procedures—particularly robotic-assisted laparoscopic prostatectomy (RALP)—affect blood coagulation and how novel anticoagulants can be safely used in these settings. In her highly cited 2013 study, Lassila provided critical retrospective evidence on the safety and efficacy of dabigatran for thromboprophylaxis after RALP in prostate cancer patients, while also analysing how the surgery itself alters coagulation markers. This work has been foundational for guiding perioperative anticoagulation strategies, earning 15 citations and influencing clinical protocols. Lassila’s research bridges the gap between surgical innovation and haematological safety, offering practical insights for reducing thromboembolic risks without compromising haemostasis. Her findings continue to inform best practices in urological oncology and perioperative medicine, making her a respected voice in the field of surgical haemostasis.
Research Focus
Key Achievements
Top Papers
- 1